Effects of pyridoxalated hemoglobin polyoxyethylene conjugate and stroma-free hemoglobin on renal vascular responsiveness to vasoactive substances in isolated perfused rat kidney.

The effects of pyridoxalated hemoglobin polyoxyethylene conjugate (PHP) and stroma-free hemoglobin (SFH) on vascular responsiveness to various vasoactive substances were examined in isolated perfused rat kidneys. The kidneys isolated from rats were perfused with 6% PHP, 6% SFH, and 6% hydroxyethylstarch (HES) solution at a constant flow rate. Vascular responsiveness to acetylcholine (ACh), nitroglycerin (NG), norepinephrine (NE), and angiotensin-II (ANG-II) was examined by measuring the perfusion pressure (PP). Effects of inhibition of endothelium-derived relaxing factor (EDRF) by NG-monomethyl L-arginine (L-NMMA) on NE-induced and ANG-II-induced renal vascular responses were examined. ACh and NG induced a dose-dependent decrease in perfusion pressure (PP) in all groups. NE and ANG-II induced an increase in PP in all groups, but NE-induced and ANG-II-induced responses in the PHP-perfused and SFH-perfused groups were significantly larger than those in the HES-perfused group. L-NMMA did not alter vascular responsiveness to NE and ANG-II. These results indicate that PHP and SFH do not inhibit EDRF induced by ACh, but hemoglobin moiety per se does augment the vascular responsiveness to NE and ANG-II in the isolated perfused rat kidney.

[1]  K. Nishi,et al.  Vascular responsiveness to various vasoactive substances after exchange transfusion with pyridoxalated hemoglobin polyoxyethylene conjugate (PHP) solution in anesthetized rats. , 2008, Artificial organs.

[2]  H. Araki,et al.  Effects of pyridoxalated hemoglobin polyoxyethylene conjugate on diameter of rat mesenteric arterioles in situ. , 1992, Artificial organs.

[3]  V. Lahera,et al.  Role of the endothelium-dependent relaxing factor nitric oxide on renal function. , 1992, Journal of the American Society of Nephrology : JASN.

[4]  D. Rodman,et al.  Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lungs. , 1991, The American journal of physiology.

[5]  P. Ramwell,et al.  Endothelium-mediated effects of N-substituted arginines on the isolated perfused rat kidney. , 1990, Journal of Pharmacology and Experimental Therapeutics.

[6]  U. Förstermann,et al.  Endothelium-derived relaxing factor influences renal vascular resistance. , 1990, The American journal of physiology.

[7]  K. Nishi,et al.  Effects of pyridoxalated hemoglobin polyoxyethylene conjugate and stroma-free hemoglobin on cardiac function in isolated rat heart. , 1990, Artificial organs.

[8]  S. Moncada,et al.  Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. , 1990, The American journal of physiology.

[9]  T. Lüscher,et al.  Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. , 1990, The Journal of clinical investigation.

[10]  T. M. Griffith,et al.  EDRF‐mediated dilatation in the rat isolated perfused kidney: a microangiographic study , 1989, British journal of pharmacology.

[11]  S. Archer,et al.  Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. , 1989, Biochemical and biophysical research communications.

[12]  M. Peach,et al.  Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. , 1988, The Journal of clinical investigation.

[13]  W. Odling‐Smee,et al.  Detection of a vasoconstrictor factor in stroma-free haemoglobin solutions. , 1988, The Journal of trauma.

[14]  C. N. Gillis,et al.  Evidence for the role of endothelium-derived relaxing factor in acetylcholine-induced vasodilatation in the intact lung. , 1987, The Journal of pharmacology and experimental therapeutics.

[15]  Y. Iwashita,et al.  Efficacy and safety of hemoglobin-polyethylene glycol conjugate (pyridoxalated polyethylene glycol hemoglobin) as an oxygen-carrying resuscitation fluid. , 1986, Artificial organs.

[16]  Y. Iwashita,et al.  Preparation and evaluation of hemoglobin-polyethylene glycol conjugate (pyridoxalated polyethylene glycol hemoglobin) as an oxygen-carrying resuscitation fluid. , 1986, Artificial organs.

[17]  C. Su,et al.  Influence of basal perfusion pressure on vasoconstrictor and vasodilator responses induced sympathetically and reflexly in pump-perfused rat hindquarters. , 1986, Archives internationales de pharmacodynamie et de therapie.

[18]  R. Dennis,et al.  Coronary constrictor effect of stroma-free hemoglobin solutions. , 1986, The American journal of physiology.

[19]  H. Harasaki,et al.  Physiologic Effects of Pyridoxalated‐Hemoglobin-Polyethylene Glycol Conjugate Solution in Exchange Transfusion , 1986, ASAIO transactions.

[20]  R. Furchgott,et al.  Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. , 1986, The Journal of pharmacology and experimental therapeutics.

[21]  R. Furchgott,et al.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. , 1985, The Journal of pharmacology and experimental therapeutics.

[22]  R. Busse,et al.  Species-dependent differences in the nature of endothelium-derived vascular relaxing factor. , 1984, European journal of pharmacology.

[23]  N. Voelkel,et al.  Actions of lipoxygenase metabolites in isolated rat lungs. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

[24]  R. Furchgott Role of endothelium in responses of vascular smooth muscle. , 1983, Circulation research.

[25]  H. Passow,et al.  Autoregulation of flow in isolated rat kidney in the absence of red cells. , 1959, The American journal of physiology.

[26]  V. Miller,et al.  Heterogeneity of Endothelium‐Dependent Responses in Mammalian Blood Vessels , 1985, Journal of cardiovascular pharmacology.